A Study of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359 in People With Solid Tumor Cancers

Full Title

A Phase I/IIa Image-Guided, Alpha-Particle Therapy Study of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359 in Patients with Solid Tumors that are Known to be Fibroblast Activation Protein (FAP)-Positive

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Lisa Bodei’s office at 212-639-7373.

Protocol
26-213
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
Lisa Bodei
Co-Investigators
Eileen M. O'Reilly
Heiko Schöder
Diseases
Solid Tumors
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06710756
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description